CoChat

Management of metabolic syndrome through probiotic and prebiotic interventions

Open access
Grover, Sunita, Mallappa, RashmiH, Rokana, Namita, Duary, RajKumar, Panwar, Harsh, Batish, VirenderKumar · 2012 · Indian Journal of Endocrinology and Metabolism
Cited by 95

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Metabolic syndrome is a complex disorder caused by a cluster of interrelated factors that increases the risk of cardiovascular diseases and type 2 diabetes. Obesity is the main precursor for metabolic syndrome that can be targeted in developing various therapies. With this view, several physical, psychological, pharmaceutical and dietary therapies have been proposed for the management of obesity. However, dietary strategies found more appropriate without any adverse health effects. Application of probiotics and prebiotics as biotherapeutics is the new emerging area in developing dietary strategies and many people are interested in learning the facts behind these health claims. Recent studies established the role of probiotics and prebiotics in weight management with possible mechanisms of improved microbial balance, decreased food intake, decreased abdominal adiposity and increased mucosal integrity with decreased inflammatory tone. Hence, the above "Pharmaco-nutritional" approach has been selected and extensively reviewed to gain thorough knowledge on putative mechanisms of probiotic and prebiotic action in order to develop dietary strategies for the management of metabolic syndrome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4103/2230-8210.91178

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 48

  1. Hays, 2008, Prevention and treatment of type 2 diabetes: Current role of lifestyle, natural product, and pharmacological interventions, Pharmacol Ther, 181
  2. Reid, 2003, Sanders ME, Gaskins HR, Gibson GR, Mercenier A, Rastall A, et al.New scientific paradigms for probiotics and prebiotics, J Clin Gastroenterol, 105
  3. Sanz, 2007, Probiotics as drugs against human gastrointestinal infections, Recent Pat Antiinfect Drug Discov, 148
  4. Cani,, 2008, Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice, Diabetes, 1470
  5. Cani, 2009, Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal, Am J Clin Nutr, 1236
  6. Delzenne, 2007, Modulation of glucagon-like peptide 1 and energy metabolism by inulin and oligofructose: Experimental data, J Nutr, 2547S
  7. Cani, 2004, Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats, Br J Nutr, 521
  8. Cani, 2005, Oligofructose promotes satiety in rats fed a high-fat diet: Involvement of glucagon-like Peptide-1, Obes Res, 1000
  9. Cani, 2006, Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide-1 receptor, Diabetes, 1484
  10. Cani, 2006, Oligofructose promotes satiety in healthy human: A pilot study, Eur J Clin Nutr, 567
  11. Nicholson, 2005, Gut microorganisms, mammalian metabolism and personalized healthcare, Nat Rev Microbiol, 431
  12. Neish, 2009, Microbes in gastrointestinal health and disease, Gastroenterology, 65
  13. Qin, 2010, A human gut microbial gene catalogue established by metagenomic sequencing, Nature, 59
  14. Eckburg, 2005, Diversity of the human intestinal microbial flora, Sci, 1635
  15. Ley, 2005, Obesity alters gut microbial ecology, Proc Natl Acad Sci USA, 11070
  16. Roberfroid, 2010, Prebiotic effects: Metabolic and health benefits, Br J Nutr, S1
  17. Mozes, 2008, Developmental changes of gut microflora and enzyme activity in rat pups exposed to fat-rich diet, Obesity, 2610
  18. Mozes, 2008, Intestinal microflora and obesity in rats, Folia Microbiologica, 225
  19. Turnbaugh, 2009, A core gut microbiome in obese and lean twins, Nature, 480
  20. Turnbaugh, 2006, An obesity-associated gut microbiome with increased capacity for energy harvest, Nature, 1027
  21. Nadal, 2009, Shifts in clostridia, bacteroides and immunoglobulin-coating fecal bacteria associated with weight loss in obese adolescents, Int J Obesity, 758
  22. Santacruz, 2009, Interplay between weight loss and gut microbiota composition in overweight adolescents, Obesity, 1906
  23. Collado, 2008, Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women, Am J Clin Nutr, 894
  24. Ley, 2006, Microbial ecology: Human gut microbes associated with obesity, Nature, 1022
  25. Kalliomaki, 2008, Early differences in fecal microbiota composition in children may predict overweight, Am J Clin Nutr, 534
  26. Kadooka, 2011, The probiotic Lactobacillus gasseri SBT2055 inhibits enlargement of visceral adipocytes and upregulation of serum soluble adhesion molecule (sICAM-1) in rats, Int Dairy J, 1
  27. Kondo, 2010, Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity, Biosci Biotechnol Biochem, 1656
  28. Rosberg-Cody, 2011, Recombinant lactobacilli expressing linoleic acid isomerase can modulate the fatty acid composition of host adipose tissue in mice, Microbiology, 609
  29. Rastmaneh, 2011, High polyphenol, low probiotic diet for weight loss because of intestinal microbiota interaction, Chem Biol Interact, 1
  30. Yadav, 2008, The effect of probiotic Dahi Containing Lactobacillus acidophilus and Lactobacillus casei on gastropathic consequences in diabetic rats, J Med Food, 62
  31. Yin, 2010, Effects of four Bifidobacteria on obesity in high-fat diet induced rats, World J Gastroenterol, 3394
  32. Aronsson, 2010, Decreased fat storage by Lactobacillus paracasei is associatedwith increased levels of angiopoietin-like 4 protein (ANGPTL4), PLoS One, e13087
  33. Piche, 2003, Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease, Gastroenterology, 894
  34. Kaji, 2011, Density distribution of free fatty acid receptor 2 (FFA2)- expressing and GLP-1-producing enteroendocrine L cells in human and rat lower intestine, and increased cell numbers after ingestion of fructo-oligosaccharide, J Mol Hist, 27
  35. Cani, 2007, Metabolic endotoxemia initiates obesity and insulin resistance, Diabetes, 1761
  36. Cani, 2007, Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats, Br J Nutr, 32
  37. Cani, 2007, Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia, Diabetologia, 2374
  38. Neyrincka AM, Possemiersb S, Verstraeteb W, Backera FD, Cani PD, Delzennea NM. Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice. J Nutr Biochem 2011 in press. · DOI · Paper page
  39. Pylkas, 2005, Comparison of different fibers for in vitro production of short chain fatty acids by intestinal microflora, J Med Food, 113
  40. Reimer, 1996, Dietary fiber modulates intestinal proglucagon messenger ribonucleic acid and postprandial secretion of glucagon- like peptide-1 and insulin in rats, Endocrinology, 3948
  41. Dumoulin, 1998, Peptide YY.Glucagon-like peptide-1, and neurotensin responses to luminal factors in the isolated vascularly perfused rat ileum, Endocrinology, 3780
  42. Parnell, 2009, Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults, Am J Clin Nutr, 1751
  43. Freeland, 2010, Adaptation of colonic fermentation and glucagon-like peptide-1 secretion with increased wheat fibre intake for 1 year in hyperinsulinaemic human subjects, Br J Nutr, 82
  44. Cani, 2009, Changes in gut microbiota control inflammation in obesemice through amechanism involving GLP-2-driven improvement of gut permeability, Gut, 1091
  45. Dewulf, 2011, Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARgamma-related adipogenesis in the white adipose tissue of high-fat diet-fed mice, J Nutr Biochem, 712
  46. Tarini, 2010, The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects, Appl Physiol Nutr Metab, 9
  47. Lefranc-Millot C, Guérin-Deremaux L, Wils D, Pochat M, Li S. Effects of a soluble dietary fiber supplementation with NUTRIOSE® on risk factors of the metabolic syndrome in Chinese male adults. Obesity Rev 2010;11:438a.s.
  48. Neyrincka AM, Possemiersb S, Verstraeteb W, Backera FD, Cani PD, Delzennea NM. Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice. J Nutr Biochem 2011 [In Press]. · DOI · Paper page

Cited by

See all 95

Metadata

Authors
Grover, S., Mallappa, R., Rokana, N., Duary, R., Panwar, H., & Batish, V.
Venue
Indian Journal of Endocrinology and Metabolism
Publisher
Medknow
Published
2012
Volume
16
Issue
1
Pages
20
ISSN
2230-8210 (ISSN-L)
OpenAlex
W2095140563
Cited by
95
References
19
FWCI
6.75
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.